HemaSphere (Apr 2022)
P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
- R Popat,
- S Usmani,
- A Garfall,
- N van de Donk,
- H Nahi,
- J San-Miguel,
- A Oriol,
- A Nooka,
- T Martin,
- L Rosinol,
- A Chari,
- L Karlin,
- L Benboubker,
- M Mateos,
- N Bahlis,
- P Moreau,
- B Besemer,
- J Martínez-López,
- S Sidana,
- L Pei,
- D Trancucci,
- R Verona,
- S Girgis,
- Y Olyslager,
- M Jaffe,
- C Uhlar,
- T Stephenson,
- R Van Rampelbergh,
- A Banerjee,
- J Goldberg,
- R Kobos,
- A Krishnan
Affiliations
- R Popat
- 1 University College London Hospitals, NHS Foundation Trust
- S Usmani
- 2 Levine Cancer Institute/Atrium Health
- A Garfall
- 3 Abramson Cancer Center, University of Pennsylvania
- N van de Donk
- 4 Amsterdam University Medical Center, Vrije Universiteit Amsterdam
- H Nahi
- 5 Karolinska University Hospital at Huddinge
- J San-Miguel
- 6 Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA
- A Oriol
- 7 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol
- A Nooka
- 8 Winship Cancer Institute, Emory University
- T Martin
- 9 University of California, San Francisco
- L Rosinol
- 10 Hospital Clínic, IDIBAPS, University of Barcelona
- A Chari
- 11 Mount Sinai School of Medicine
- L Karlin
- 12 Service d’Hématologie Clinique, Centre Hospitalier Lyon Sud
- L Benboubker
- 13 Service d’Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire
- M Mateos
- 14 University Hospital of Salamanca/IBSAL/CIC/CIBERONC
- N Bahlis
- 15 Arnie Charbonneau Cancer Institute, University of Calgary
- P Moreau
- 16 Hematology Clinic, University Hospital Hôtel-Dieu
- B Besemer
- 17 Department of Hematology, Oncology and Immunology, University of Tuebingen
- J Martínez-López
- 18 Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC
- S Sidana
- 19 Stanford University School of Medicine
- L Pei
- 20 Janssen Research & Development
- D Trancucci
- 20 Janssen Research & Development
- R Verona
- 21 Janssen Research & Development
- S Girgis
- 21 Janssen Research & Development
- Y Olyslager
- 22 Janssen Research & Development
- M Jaffe
- 20 Janssen Research & Development
- C Uhlar
- 21 Janssen Research & Development
- T Stephenson
- 21 Janssen Research & Development
- R Van Rampelbergh
- 22 Janssen Research & Development
- A Banerjee
- 21 Janssen Research & Development
- J Goldberg
- 20 Janssen Research & Development
- R Kobos
- 20 Janssen Research & Development
- A Krishnan
- 23 City of Hope Comprehensive Cancer Center
- DOI
- https://doi.org/10.1097/01.HS9.0000829596.42296.29
- Journal volume & issue
-
Vol. 6
pp. 14 – 14
Abstract
No abstracts available.
